These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 202015

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Resistance of guinea-pig hepatoma cells to complement-mediated lysis induced by ascites fluid or serum from tumor-bearing animals.
    Abe S, Berczi I, Sehon AH.
    Int J Cancer; 1977 Oct 15; 20(4):595-606. PubMed ID: 199549
    [Abstract] [Full Text] [Related]

  • 5. Isolation and characterization of tumour-specific antigen from the serum of rats bearing transplanted aminoazo dye-induced hepatomas.
    Bowen JG, Baldwin RW.
    Transplantation; 1976 Mar 15; 21(3):213-9. PubMed ID: 59982
    [Abstract] [Full Text] [Related]

  • 6. Detection of circulating hepatoma D23 antigen and immune complexes in tumour bearer serum.
    Baldwin RW, Bowen JG, Price MR.
    Br J Cancer; 1973 Jul 15; 28(1):16-24. PubMed ID: 4353387
    [Abstract] [Full Text] [Related]

  • 7. Serum factors modifying cell mediated immunity to rat hepatoma d23 correlated with tumour growth.
    Bowen JG, Robins RA, Baldwin RW.
    Int J Cancer; 1975 Apr 15; 15(4):640-50. PubMed ID: 166943
    [Abstract] [Full Text] [Related]

  • 8. Tumour-associated antigens reacting with cytotoxic antibodies in serum of hepatoma-bearing rats.
    Lando P, Berzins K, Gabriel J, Larsson P, Perlmann P.
    Br J Cancer; 1981 Oct 15; 44(4):522-31. PubMed ID: 7295508
    [Abstract] [Full Text] [Related]

  • 9. Cytotoxicity of tumour-bearer serum to D23 hepatoma cells derived from solid tumours, ascites or in vitro cultures.
    Lando P, Gabriel J, Berzins K, Perlmann P.
    Scand J Immunol; 1982 Mar 15; 15(3):259-66. PubMed ID: 7089487
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Preparation of aminoazo dye induced rat hepatoma membrane fractions retaining tumour specific antigen.
    Price MR, Baldwin RW.
    Br J Cancer; 1974 Nov 15; 30(5):382-93. PubMed ID: 4143271
    [Abstract] [Full Text] [Related]

  • 12. A tumor-specific cytotoxic and neutralizing factor in rats immunized with ascites hepatoma induced by azo dyes.
    El-Asfahani AM, Mizuno D, Hashimoto Y, Ishidate M, Nishioka K.
    Gan; 1975 Feb 15; 66(1):11-9. PubMed ID: 168113
    [Abstract] [Full Text] [Related]

  • 13. Activity of syngeneic complement for revealing antibody-induced cytotoxicity against a rat hepatoma.
    Price MR, Höffken K, Baldwin RW.
    Transplantation; 1979 Aug 15; 28(2):140-3. PubMed ID: 483360
    [Abstract] [Full Text] [Related]

  • 14. Susceptibility to and escape from complement-mediated lysis of guinea-pig hepatoma line-10.
    Abe S, Berczi I, Sehon AH.
    Int J Cancer; 1977 Jul 15; 20(1):137-45. PubMed ID: 198379
    [Abstract] [Full Text] [Related]

  • 15. Serum antibody responses to an ascitic variant of rat hepatoma D23.
    Robins RA.
    Br J Cancer; 1975 Jul 15; 32(1):21-7. PubMed ID: 169868
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunogenicity of rat hepatoma membrane fractions.
    Baldwin RW, Embleton MJ, Moore M.
    Br J Cancer; 1973 Nov 15; 28(5):389-99. PubMed ID: 4357132
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of hepatoma-immune lymph-node cell cytotoxicity by tumour-bearer serum, and solubilized hepatoma antigen.
    Baldwin RW, Price MR, Robins RA.
    Int J Cancer; 1973 May 15; 11(3):527-35. PubMed ID: 4364717
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.